Gastroelectric stimulation for influencing pancreatic secretions
0 Assignments
0 Petitions
Accused Products
Abstract
A gastroelectric stimulator comprises a neurostimulator for producing a stimulation signal, at least one electrical lead, and at least two electrical contacts. The electrical lead has a proximal end and a distal end, the proximal end being connected to the neurostimulator and the distal end positionable in a lead position within the patient'"'"'s abdomen. The electrodes are carried near the electrical lead distal end. The electrodes are electrically connected through the electrical lead to the neurostimulator to receive the stimulation signal and convey this signal to an electrode position within the patient'"'"'s digestive system. The stimulation signal is adapted to influence pancreatic secretions.
31 Citations
68 Claims
-
1. (Cancelled)
-
2. (Cancelled)
-
3. (Cancelled)
-
4. (Cancelled)
-
5. (Cancelled)
-
6. (Cancelled)
-
7. (Cancelled)
-
8. (Cancelled)
-
9. (Cancelled)
-
10. (Cancelled)
-
11. (Cancelled)
-
12. (Cancelled)
-
13. (Cancelled)
-
14. (Cancelled)
-
15. (Cancelled)
-
16. (Cancelled)
-
17. (Cancelled)
-
18. (Cancelled)
-
19. (Cancelled)
-
20. (Cancelled)
-
21. (Cancelled)
-
22. (Cancelled)
-
23. (Cancelled)
-
24. (Cancelled)
-
25. (Cancelled)
-
26. (Cancelled)
-
27. (Cancelled)
-
28. (Cancelled)
-
29. (Cancelled)
-
30. A method for decreasing pancreatic exocrine secretions in a patient, comprising:
-
applying at least two electrodes to a digestive system of the patient that are coupled by at least one lead to a neurostimulator;
stimulating the digestive system with a stimulation signal generated by the neurostimulator and conveyed through the lead to the electrode contacting the digestive system, wherein the digestive system stimulation is transmitted to a pancreas of a patient, and wherein pancreatic exocrine secretion is decreased by the digestive system stimulation. - View Dependent Claims (44, 46, 47, 48, 50, 51)
-
-
31. (Cancelled)
-
32. (Cancelled)
-
33. (Cancelled)
-
34. (Cancelled)
-
35. (Cancelled)
-
36. (Cancelled)
-
37. (Cancelled)
-
38. (Cancelled)
-
39. (Cancelled)
-
40. (Cancelled)
-
41. (Cancelled)
-
42. (Cancelled)
-
43. (Cancelled)
- 52. The method of 30, further comprising measuring a patient condition and controlling the stimulation signal in response to the measured patient condition.
-
55. A method for treating pancreatic endocrine conditions in a patient, comprising:
-
applying at least two electrodes to a digestive system of the patient that are coupled by at least one lead to a neurostimulator;
stimulating the digestive system with a stimulation signal generated by the neurostimulator and conveyed through the lead to the electrode contacting the digestive system, wherein the digestive system stimulation is transmitted to a pancreas of a patient, and wherein pancreatic endocrine output is influenced by the digestive system stimulation. - View Dependent Claims (56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68)
-
Specification